Los Angeles - The use of lipid-lowering drugs may inhibit the development of melanoma, according to results of two separate studies presented at the annual meeting of the Society for Investigative Dermatology.
Melasma Significantly Impacts Quality of Life Among Patients With Darker Skin Types
The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients
Bemcentinib Plus SOC Is Well Tolerated, But Does Not Improve Efficacy in Metastatic Melanoma
The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium
Samsung Bioepis Receives US License Date for Proposed Ustekinumab Biosimilar, SB17
Discovering Dermatology Times: November 2023 Corticosteroid-Responsive Dermatoses Supplement